241 related articles for article (PubMed ID: 23266873)
1. Murine isoforms of UDP-GlcNAc 2-epimerase/ManNAc kinase: Secondary structures, expression profiles, and response to ManNAc therapy.
Yardeni T; Jacobs K; Niethamer TK; Ciccone C; Anikster Y; Kurochkina N; Gahl WA; Huizing M
Glycoconj J; 2013 Aug; 30(6):609-18. PubMed ID: 23266873
[TBL] [Abstract][Full Text] [Related]
2. Non-specific accumulation of glycosphingolipids in GNE myopathy.
Patzel KA; Yardeni T; Le Poëc-Celic E; Leoyklang P; Dorward H; Alonzi DS; Kukushkin NV; Xu B; Zhang Y; Sollogoub M; Blériot Y; Gahl WA; Huizing M; Butters TD
J Inherit Metab Dis; 2014 Mar; 37(2):297-308. PubMed ID: 24136589
[TBL] [Abstract][Full Text] [Related]
3. Safety, pharmacokinetics and sialic acid production after oral administration of N-acetylmannosamine (ManNAc) to subjects with GNE myopathy.
Xu X; Wang AQ; Latham LL; Celeste F; Ciccone C; Malicdan MC; Goldspiel B; Terse P; Cradock J; Yang N; Yorke S; McKew JC; Gahl WA; Huizing M; Carrillo N
Mol Genet Metab; 2017 Sep; 122(1-2):126-134. PubMed ID: 28641925
[TBL] [Abstract][Full Text] [Related]
4. Identification, tissue distribution, and molecular modeling of novel human isoforms of the key enzyme in sialic acid synthesis, UDP-GlcNAc 2-epimerase/ManNAc kinase.
Yardeni T; Choekyi T; Jacobs K; Ciccone C; Patzel K; Anikster Y; Gahl WA; Kurochkina N; Huizing M
Biochemistry; 2011 Oct; 50(41):8914-25. PubMed ID: 21910480
[TBL] [Abstract][Full Text] [Related]
5. Molecular modeling of the bifunctional enzyme UDP-GlcNAc 2-epimerase/ManNAc kinase and predictions of structural effects of mutations associated with HIBM and sialuria.
Kurochkina N; Yardeni T; Huizing M
Glycobiology; 2010 Mar; 20(3):322-37. PubMed ID: 19917666
[TBL] [Abstract][Full Text] [Related]
6. Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine.
Galeano B; Klootwijk R; Manoli I; Sun M; Ciccone C; Darvish D; Starost MF; Zerfas PM; Hoffmann VJ; Hoogstraten-Miller S; Krasnewich DM; Gahl WA; Huizing M
J Clin Invest; 2007 Jun; 117(6):1585-94. PubMed ID: 17549255
[TBL] [Abstract][Full Text] [Related]
7. Biochemical characterization of human and murine isoforms of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE).
Reinke SO; Eidenschink C; Jay CM; Hinderlich S
Glycoconj J; 2009 May; 26(4):415-22. PubMed ID: 18815882
[TBL] [Abstract][Full Text] [Related]
8. Oral monosaccharide therapies to reverse renal and muscle hyposialylation in a mouse model of GNE myopathy.
Niethamer TK; Yardeni T; Leoyklang P; Ciccone C; Astiz-Martinez A; Jacobs K; Dorward HM; Zerfas PM; Gahl WA; Huizing M
Mol Genet Metab; 2012 Dec; 107(4):748-55. PubMed ID: 23122659
[TBL] [Abstract][Full Text] [Related]
9. UDP-GlcNAc 2-Epimerase/ManNAc Kinase (GNE): A Master Regulator of Sialic Acid Synthesis.
Hinderlich S; Weidemann W; Yardeni T; Horstkorte R; Huizing M
Top Curr Chem; 2015; 366():97-137. PubMed ID: 23842869
[TBL] [Abstract][Full Text] [Related]
10. Lec3 Chinese hamster ovary mutants lack UDP-N-acetylglucosamine 2-epimerase activity because of mutations in the epimerase domain of the Gne gene.
Hong Y; Stanley P
J Biol Chem; 2003 Dec; 278(52):53045-54. PubMed ID: 14561743
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of
Peters E; Selke P; Bork K; Horstkorte R; Gesper A
Front Biosci (Landmark Ed); 2023 Nov; 28(11):300. PubMed ID: 38062838
[TBL] [Abstract][Full Text] [Related]
12. Visualizing Muscle Sialic Acid Expression in the GNED207VTgGne-/- Cmah-/- Model of GNE Myopathy: A Comparison of Dietary and Gene Therapy Approaches.
Crowe KE; Zygmunt DA; Heller K; Rodino-Klapac L; Noguchi S; Nishino I; Martin PT
J Neuromuscul Dis; 2022; 9(1):53-71. PubMed ID: 34511508
[TBL] [Abstract][Full Text] [Related]
13. GNE myopathy: new name and new mutation nomenclature.
Huizing M; Carrillo-Carrasco N; Malicdan MC; Noguchi S; Gahl WA; Mitrani-Rosenbaum S; Argov Z; Nishino I
Neuromuscul Disord; 2014 May; 24(5):387-9. PubMed ID: 24685570
[No Abstract] [Full Text] [Related]
14. [Animal model of distal myopathy with rimmed vacuoles/hereditary inclusion body myopathy and preclinical trial with sugar compounds].
Noguchi S; Malicdan MC; Nishino I
Brain Nerve; 2010 Jun; 62(6):601-7. PubMed ID: 20548120
[TBL] [Abstract][Full Text] [Related]
15. GNE deficiency impairs Myogenesis in C2C12 cells and cannot be rescued by ManNAc supplementation.
Neu CT; Weilepp L; Bork K; Gesper A; Horstkorte R
Glycobiology; 2024 Apr; 34(3):. PubMed ID: 38224318
[TBL] [Abstract][Full Text] [Related]
16. Mutation update for GNE gene variants associated with GNE myopathy.
Celeste FV; Vilboux T; Ciccone C; de Dios JK; Malicdan MC; Leoyklang P; McKew JC; Gahl WA; Carrillo-Carrasco N; Huizing M
Hum Mutat; 2014 Aug; 35(8):915-26. PubMed ID: 24796702
[TBL] [Abstract][Full Text] [Related]
17. A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy.
Malicdan MC; Noguchi S; Nonaka I; Hayashi YK; Nishino I
Hum Mol Genet; 2007 Nov; 16(22):2669-82. PubMed ID: 17704511
[TBL] [Abstract][Full Text] [Related]
18. Novel GNE mutations in hereditary inclusion body myopathy patients of non-Middle Eastern descent.
Saechao C; Valles-Ayoub Y; Esfandiarifard S; Haghighatgoo A; No D; Shook S; Mendell JR; Rosales-Quintero X; Felice KJ; Morel CF; Pietruska M; Darvish D
Genet Test Mol Biomarkers; 2010 Apr; 14(2):157-62. PubMed ID: 20059379
[TBL] [Abstract][Full Text] [Related]
19. Novel GNE mutations in autosomal recessive hereditary inclusion body myopathy patients.
No D; Valles-Ayoub Y; Carbajo R; Khokher Z; Sandoval L; Stein B; Tarnopolsky MA; Mozaffar T; Darvish B; Pietruszka M; Darvish D
Genet Test Mol Biomarkers; 2013 May; 17(5):376-82. PubMed ID: 23437777
[TBL] [Abstract][Full Text] [Related]
20. [Sialic acid supplementation therapy for distal myopathy with rimmed vacuoles (GNE myopathy)].
Nishino I; Noguchi S
Rinsho Shinkeigaku; 2012; 52(11):1210-2. PubMed ID: 23196566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
